Avro Life Science appears in Y Combinator's company directory in the Winter 2018 batch, listed 2017-11-02. Skin patches for generic drug delivery. .
Avro Life Science is a Y Combinator company in the Winter 2018 batch. Its directory entry describes it as: Skin patches for generic drug delivery. The founders listed are Shak Lakhani (Founder), Keean Sarani (Founder) (Y Combinator directory entry, November 2, 2017).
Sell to companies like Avro Life Science? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2017-11-02 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Avro Life Science.
Free to see. No signup.
More on Avro Life Science and the records around it.
Same batch, Healthcare first.
Get an email when Avro Life Science changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Avro Life Science raises, hires or launches. No email unless you switch it on.
Watch Avro Life Science →Get the full cited report on Avro Life Science
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Avro Life Science: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Checked away from the directory entry. What is below does not come from the company's Y Combinator page.
A clinical stage biotech redefining the skin’s potential as a target for novel first-in-class Therapies.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Avro Life Science: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Avro Life Science covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Avro Life ScienceYou get an alert in MentionFox the next time this company shows up.
If you're behind Avro Life Science: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, and from the company's own site, read directly on 2026-09-27 (avrolifesci.com).
Each opens in a new tab, filled in for Avro Life Science. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.
https://mentionfox.com/funding/yc-avro-life-science